Clinical trial
BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously…
NCT00017043 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00017043 |
|---|---|
| Title | BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy |
| Official title | A Phase II Study of Epothilone Analog BMS-247550 in Patients With Metastatic Gastric Adenocarcinoma Previously Treated With a Taxane |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer, Gastric Cancer |
| Intervention type | Drug |
| Interventions | ixabepilone |
| Start date | Feb 1, 2001 |
| Primary completion | Jan 1, 2003 |
| Completion | Jan 1, 2003 |
| First posted | Sep 9, 2003 |
| Last update posted | Apr 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: